Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Kurt Racké x
  • Refine by access: All content x
Clear All Modify Search
Carolin Maria Frisch
Search for other papers by Carolin Maria Frisch in
Google Scholar
PubMed
Close
,
Katrin Zimmermann
Search for other papers by Katrin Zimmermann in
Google Scholar
PubMed
Close
,
Pia Zilleßen Institute of Pharmacology and Toxicology, Federal Institute for Drugs and Medical Devices (BfArM), University of Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany

Search for other papers by Pia Zilleßen in
Google Scholar
PubMed
Close
,
Alexander Pfeifer
Search for other papers by Alexander Pfeifer in
Google Scholar
PubMed
Close
,
Kurt Racké
Search for other papers by Kurt Racké in
Google Scholar
PubMed
Close
, and
Peter Mayer Institute of Pharmacology and Toxicology, Federal Institute for Drugs and Medical Devices (BfArM), University of Bonn, Sigmund-Freud-Straße 25, 53127 Bonn, Germany

Search for other papers by Peter Mayer in
Google Scholar
PubMed
Close

Insulin plays an important role as a growth factor and its contribution to tumor proliferation is intensely discussed. It acts via the cognate insulin receptor (IR) but can also activate the IGF1 receptor (IGF1R). Apart from increasing proliferation, insulin might have additional effects in lung cancer. Therefore, we investigated insulin action and effects of IR knockdown (KD) in three (NCI-H292, NCI-H226 and NCI-H460) independent non-small cell lung cancer (NSCLC) cell lines. All lung cancer lines studied were found to express IR, albeit with marked differences in the ratio of the two variants IR-A and IR-B. Insulin activated the classical signaling pathway with IR autophosphorylation and Akt phosphorylation. Moreover, activation of MAPK was observed in H292 cells, accompanied by enhanced proliferation. Lentiviral shRNA IR KD caused strong decrease in survival of all three lines, indicating that the effects of insulin in lung cancer go beyond enhancing proliferation. Unspecific effects were ruled out by employing further shRNAs and different insulin-responsive cells (human pre-adipocytes) for comparison. Caspase assays demonstrated that IR KD strongly induced apoptosis in these lung cancer cells, providing the physiological basis of the rapid cell loss. In search for the underlying mechanism, we analyzed alterations in the gene expression profile in response to IR KD. A strong induction of certain cytokines (e.g. IL20 and tumour necrosis factor) became obvious and it turned out that these cytokines trigger apoptosis in the NSCLC cells tested. This indicates a novel role of IR in tumor cell survival via suppression of pro-apoptotic cytokines.

Free access